UCL cancer institute data access commitee

Gerhardt Attard
g.attard@ucl.ac.uk

Request Access

Dataset ID	Description	Technology	Samples
EGAD00001008800	We copy number profiled 688 tumor regions from 300 patients presenting with advanced prostate cancer and prospectively followed-up (median, 7 years) in the control group of the STAMPEDE trial. Patients were categorised into four metastatic states, namely high-risk non-metastatic (with or without local lymph node involvement) or metastatic (low or high volume).	Illumina NovaSeq 6000	603